Confort urinaire - Macérat dynamisé
Food supplement declared in France, declaration No 2023-7-193, decision dated 4 July 2023
Confort urinaire - Macérat dynamisé (VESUNNA) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Calluna vulgaris 30 mg per day, Juniperus communis 30 mg per day, Vaccinium vitis-idaea 30 mg per day, miel d’acacia. 2 rules of use apply to its ingredients (limits and warnings).
- Brand
- VESUNNA
- Food business operator placing the product on the market
- VESUNNA
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Dropper
- Daily dose
- 5 ml
- Directions for use
- 50 à 150 gouttes par jour en 2 à 3 prises dans un peu d'eau
- Not recommended (according to the manufacturer)
- Breastfeeding women, History of breast cancer, Young children (aged 1 to 3), Pregnant women, Kidney failure, Infants (under 1 year), Prolonged use
- Objectives stated by the manufacturer (these are not authorised claims)
- Urinary system
Declaration 197402, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Calluna vulgaris (L.) Hull | Jeune pousse | Autre macérât | 30 mg |
| Juniperus communis L. | Jeune pousse | Autre macérât | 30 mg |
| Vaccinium vitis-idaea L. | Jeune pousse | Autre macérât | 30 mg |
Other active ingredients
| Name | Per day |
|---|---|
| miel d’acacia | not declared |
Other ingredients
Alcool éthylique, Eau purifiée
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Demander l'avis de votre médecin. Ne pas dépasser la dose journalière recommandée. Déconseillé aux femmes enceintes et allaitantes et en cas d'antécédent de cancer hormono-dépendant.Ne pas utiliser en cas d'insuffisance rénale et de façon prolongée.Tenir hors de portée des jeunes enfants. Déconseillé aux enfants.Ne peut se substituer à une alimentation équilibrée et variée.
Regulatory points
- Conditions légales
Juniperus communis L.: L'étiquetage doit comporter un avertissement recommandant de ne pas utiliser en cas d'insuffisance rénale et un avertissement recommandant de ne pas utiliser de manière prolongée (maximum 6 semaines)
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Vaccinium vitis-idaea L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Juniperus communis L.
Read the warning, when it applies and the studies cited
Juniper - Juniperus Communis
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Mills et al. 2006).
Sources cited by Health Canada (1)
- Mills E, Dugoua J, Perri D, Koren G. Herbal Medicines in Pregnancy and Lactation: An Evidence-Based Approach. London (UK): Taylor and Francis Medical; 2006.
Contraindications
Do not use if you are pregnant (Brinker 2010; Bradley 2006; ESCOP 2003; Hoffmann 2003).
Sources cited by Health Canada (4)
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
Do not use if you have a kidney disorder (Brinker 2010; Bradley 2006; ESCOP 2003; Hoffmann 2003).
Sources cited by Health Canada (4)
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : VESUNNA
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Confort urinaire - Macérat dynamisé (VESUNNA): composition and regulation”, https://compoatlas.com/en/supplements/products/197402-confort-urinaire-macerat-dynamise, updated 15 November 2026.